Health Catalyst, Inc. (HCAT)
After hours:
| Previous Close | 7.66 |
| Open | 7.68 |
| Bid | 8.08 x 100 |
| Ask | 8.17 x 100 |
| Day's Range | 7.66 - 8.25 |
| 52 Week Range | 5.42 - 11.41 |
| Volume | |
| Avg. Volume | 484,148 |
| Market Cap | 494.692M |
| Beta (5Y Monthly) | 1.33 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.34 |
| Earnings Date | Feb 20, 2025 - Feb 24, 2025 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.54 |
PR NewswireHealth Catalyst Launches AI-Enabled Cyber Protection Product for Healthcare
Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the launch of an AI-powered version of BluePrint Protect™ from Intraprise Health, LLC ("Intraprise Health"), a platform that empowers healthcare organizations to screen and identify risks related to cybersecurity threats through third parties.
GlobeNewswireHealth Catalyst to Participate in Upcoming Investor Conferences
SALT LAKE CITY, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that members of leadership will participate in the following upcoming investor conferences: The Citi 2024 Global Healthcare Conference, being held in Miami, including a fireside chat with Dan Burton, Chief Executive Officer, and Jason Alger, Chief Financial Officer, on Tuesday, Dece
